The House of Lords Clarifies “Biogen Insufficiency”

Authors

  • Eddy D. Ventose * Attorney-at-Law

DOI:

https://doi.org/10.2966/scrip.060309.718

Abstract

The author considers the recent House of Lords’ jurisprudence on “Biogen insufficiency”, arising from its 1997 decision in Biogen Inc v Medeva Plc, which holds that unless claims in the patent specification correspond to the teachings of the patent, the patent will be invalid.

Downloads

Download data is not yet available.

Downloads

Published

01-Dec-2009

Issue

Section

Analysis